Lea Gvozdanović, Željka Dragila, Z. Gvozdanović, D. Klapan, Nikolina Farčić, H. Šimić, Z. Mihaljević
{"title":"综合医院COVID-19患者常见合并症与预后的关系Našice -一项横断面研究","authors":"Lea Gvozdanović, Željka Dragila, Z. Gvozdanović, D. Klapan, Nikolina Farčić, H. Šimić, Z. Mihaljević","doi":"10.26332/seemedj.v6i1.236","DOIUrl":null,"url":null,"abstract":"Aim: The aim was to define the impact of comorbidities, specifically hypertension as one of the most common chronic diseases, on the outcome and length of stay for COVID-19 patients.Methods: The cross-sectional study, carried out from October to December 2021, included 129 hospitalised COVID-19 patients who presented to the Emergency Department and were hospitalised and treated in the COVID ward in the General Hospital Našice. All patients tested positive for COVID-19 with a polymerase chain reaction (PCR) test. Clinical parameters were also recorded and they included demographic factors, comorbidities, type of antihypertensive therapy, new-onset hypertension, length of stay and the overall outcome.Results: The most common comorbidity was hypertension (86, 66.7%). Hypertension was associated with women (P = 0.03) and age over 65 years (P < 0.001). Length of stay was longer for patients with hypertension (P = 0.04) and/or diabetes mellitus (P = 0.04). Higher mortality was associated with age over 65 years (P < 0.001) and a higher number of comorbidities (P = 0.01). New-onset hypertension was recorded in three patients. There was no significant difference in the outcome in relation to antihypertensive therapy.Conclusion: Hypertension is the most common comorbidity in hospitalised COVID-19 patients. Although treated hypertension did not have a negative impact on the outcome, other potential risk factors, including a higher number of comorbidities and older age, are associated with mortality in COVID-19 patients.","PeriodicalId":265607,"journal":{"name":"Southeastern European medical journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-04-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association Between Common Comorbidities and Outcomes in COVID-19 Patients Hospitalised in General Hospital Našice – A Cross-Sectional Study\",\"authors\":\"Lea Gvozdanović, Željka Dragila, Z. Gvozdanović, D. Klapan, Nikolina Farčić, H. Šimić, Z. Mihaljević\",\"doi\":\"10.26332/seemedj.v6i1.236\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Aim: The aim was to define the impact of comorbidities, specifically hypertension as one of the most common chronic diseases, on the outcome and length of stay for COVID-19 patients.Methods: The cross-sectional study, carried out from October to December 2021, included 129 hospitalised COVID-19 patients who presented to the Emergency Department and were hospitalised and treated in the COVID ward in the General Hospital Našice. All patients tested positive for COVID-19 with a polymerase chain reaction (PCR) test. Clinical parameters were also recorded and they included demographic factors, comorbidities, type of antihypertensive therapy, new-onset hypertension, length of stay and the overall outcome.Results: The most common comorbidity was hypertension (86, 66.7%). Hypertension was associated with women (P = 0.03) and age over 65 years (P < 0.001). Length of stay was longer for patients with hypertension (P = 0.04) and/or diabetes mellitus (P = 0.04). Higher mortality was associated with age over 65 years (P < 0.001) and a higher number of comorbidities (P = 0.01). New-onset hypertension was recorded in three patients. There was no significant difference in the outcome in relation to antihypertensive therapy.Conclusion: Hypertension is the most common comorbidity in hospitalised COVID-19 patients. Although treated hypertension did not have a negative impact on the outcome, other potential risk factors, including a higher number of comorbidities and older age, are associated with mortality in COVID-19 patients.\",\"PeriodicalId\":265607,\"journal\":{\"name\":\"Southeastern European medical journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-04-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Southeastern European medical journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.26332/seemedj.v6i1.236\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Southeastern European medical journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.26332/seemedj.v6i1.236","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Association Between Common Comorbidities and Outcomes in COVID-19 Patients Hospitalised in General Hospital Našice – A Cross-Sectional Study
Aim: The aim was to define the impact of comorbidities, specifically hypertension as one of the most common chronic diseases, on the outcome and length of stay for COVID-19 patients.Methods: The cross-sectional study, carried out from October to December 2021, included 129 hospitalised COVID-19 patients who presented to the Emergency Department and were hospitalised and treated in the COVID ward in the General Hospital Našice. All patients tested positive for COVID-19 with a polymerase chain reaction (PCR) test. Clinical parameters were also recorded and they included demographic factors, comorbidities, type of antihypertensive therapy, new-onset hypertension, length of stay and the overall outcome.Results: The most common comorbidity was hypertension (86, 66.7%). Hypertension was associated with women (P = 0.03) and age over 65 years (P < 0.001). Length of stay was longer for patients with hypertension (P = 0.04) and/or diabetes mellitus (P = 0.04). Higher mortality was associated with age over 65 years (P < 0.001) and a higher number of comorbidities (P = 0.01). New-onset hypertension was recorded in three patients. There was no significant difference in the outcome in relation to antihypertensive therapy.Conclusion: Hypertension is the most common comorbidity in hospitalised COVID-19 patients. Although treated hypertension did not have a negative impact on the outcome, other potential risk factors, including a higher number of comorbidities and older age, are associated with mortality in COVID-19 patients.